|
【结 构 式】 
|
【药物名称】MCB-116 【化学名称】7-[4-[4-[5(S)-(Acetamidomethyl)-2-oxooxazolidin-3-yl]-2-fluorophenyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 【CA登记号】444335-12-0 【 分 子 式 】C29H29F2N5O6 【 分 子 量 】581.58118 |
【开发单位】Pfizer (Originator), Morphochem (Not Determined) 【药理作用】Antibacterial Drugs, ANTIINFECTIVE THERAPY, Oxazolidinones, Quinolones |
合成路线1
The title adduct is prepared by condensation between the piperazinyl oxazolidinone derivative (I) and chloroquinoline (II) in hot N-methylpyrrolidinone.
| 【1】 Locher, H.H.; Specklin, J.; Borer, Y.; Brohammer, S.; Schroeder, S.; Sigwalt, C.; Hubschwerlen, C.; Synthesis and antibacterial action of novel quinolone-linked oxazolidinones. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1317. |
| 【2】 Barbachyn, M.R.; Patel, D.V.; Gage, J.R.; Gordeev, M.F. (Pharmacia Corp.); Antimicrobial quinolone derivs. and use of the same to treat bacterial infections. WO 0259116 . |
Extended Information